Literature DB >> 12744772

CD2-CD48 interactions promote cytotoxic T lymphocyte induction and function: anti-CD2 and anti-CD48 antibodies impair cytokine synthesis, proliferation, target recognition/adhesion, and cytotoxicity.

Bruce L Musgrave1, Carrie L Watson, David W Hoskin.   

Abstract

The role of CD2 signaling in cytotoxic T lymphocyte (CTL) development was examined by stimulating mouse T cells with anti-CD3 monoclonal antibody (mAb) in the absence or presence of anti-CD2 mAb or anti-CD48 mAb or both. Induction of nonspecific CTL and interleukin-2 (IL-2) and interferon-gamma (IFN-gamma) synthesis were impaired in the absence of CD2-CD48 interactions. Anti-CD2 mAb also inhibited activation-induced expression of the high-affinity IL-2 receptor (IL-2R). In contrast, IFN-gamma receptor (IFNGR) expression was increased in the presence of anti-CD2 mAb. Reduced cytotoxicity by CTL induced in the absence of CD2-CD48 interactions was associated with a diminished ability of CTL to conjugate with target cells and reduced expression of granzyme B and perforin. Anti-CD2 mAb did not affect expression of Fas ligand and tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) by anti-CD3-activated T cells. Cytotoxic effector function and granzyme B and perforin expression were rescued when exogenous IL-2 and IFN-gamma were added in combination with anti-CD2 mAb to anti-CD3-activated T cells at initiation of culture. We conclude that CD2-CD48 interactions during T cell activation are critical for the synthesis of sufficient IL-2 and IFN-gamma to drive CD8(+) T cells to differentiate into functional cytotoxic effector cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12744772     DOI: 10.1089/107999003321455462

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  5 in total

1.  Inhibition of cell adhesion and immune responses in the mouse model of collagen-induced arthritis with a peptidomimetic that blocks CD2-CD58 interface interactions.

Authors:  Ameya S Gokhale; Rushikesh Sable; Jason D Walker; Leslie McLaughlin; Konstantin G Kousoulas; Seetharama D Jois
Journal:  Biopolymers       Date:  2015-11       Impact factor: 2.505

Review 2.  Roles of CD48 in regulating immunity and tolerance.

Authors:  Shannon L McArdel; Cox Terhorst; Arlene H Sharpe
Journal:  Clin Immunol       Date:  2016-01-18       Impact factor: 3.969

3.  Exchange of cytosolic content between T cells and tumor cells activates CD4 T cells and impedes cancer growth.

Authors:  Matthias Hardtke-Wolenski; Lilli Kraus; Christel Schmetz; Britta Trautewig; Fatih Noyan; Florian W R Vondran; Hueseyin Bektas; Juergen Klempnauer; Elmar Jaeckel; Thorsten Lieke
Journal:  PLoS One       Date:  2013-10-24       Impact factor: 3.240

4.  A dynamic transcriptomic atlas of cytokine-induced killer cells.

Authors:  Mingyao Meng; Lin Li; Ruhong Li; Wenju Wang; Yang Chen; Yanhua Xie; Rui Han; Kai Zhu; Wenwen Huang; Lili Yang; Shuo Li; Jianlin Shi; Weiwei Tan; Hui Gao; Yiyi Zhao; Li Yang; Jing Tan; Zongliu Hou
Journal:  J Biol Chem       Date:  2018-10-17       Impact factor: 5.157

Review 5.  Co-Stimulatory Receptors in Cancers and Their Implications for Cancer Immunotherapy.

Authors:  Seongju Jeong; Su-Hyung Park
Journal:  Immune Netw       Date:  2020-02-07       Impact factor: 6.303

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.